CD274 and neoplasm: The expression levels of programmed cell death-ligand 1 (PD-L1) are the most commonly used efficacy predictive biomarkers in AGC clinical trials (34), and CPS proved to be a more useful assessment method than tumor proportion score (TPS) in determining PD-L1 expression (35).